Most Read Articles
Stephen Padilla, 4 days ago
Treatment with oral thrombopoietin receptor agonist eltrombopag leads to similar platelet counts in patients with chronic immune thrombocytopaenia (cITP) and persistent (per)ITP, according to the results of phase III (EXTEND) and IV studies presented at the 23rd Congress of the European Hematology Association (EHA 2018) held in Stockholm, Sweden.
4 days ago
Socioeconomic status, along with other social determinants, appears to influence the long-term outcomes in Asian acute heart failure patients, according to a recent Japan study.
Pearl Toh, 6 days ago
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
Jairia Dela Cruz, 4 days ago
A treatment regimen combining daratumumab plus bortezomib, melphalan and prednisone markedly extends progression-free survival in patients with multiple myeloma, inducing deep responses and demonstrating acceptable tolerability regardless of baseline renal function, according to the results of the phase III ALCYONE study.

Higher BMI predicts adverse renal events in type 2 diabetes

14 Feb 2018

Higher body mass index (BMI) appears to be independently associated with the risk of renal disease among patients with type 2 diabetes (T2D), a study has shown.

Researchers evaluated the relationship between BMI and the risk of major renal events in 10,537 T2DM patients (mean age 66 years; 58 percent male; mean diabetes duration, 8 years) enrolled in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study.

Of the patients, 58 were underweight (BMI <18.5 kg/m2), 2,894 were of normal weight (BMI ≥18.5 to <25 kg/m2), 4,340 were overweight (BMI ≥25 to <30 kg/m2), 2,265 had grade 1 obesity (BMI ≥30 to <35 kg/m2), 744 had grade 2 obesity (BMI ≥35 to <40 kg/m2) and 294 had grade 3 obesity (BMI ≥40 kg/m2). Those who were underweight were excluded in the analysis.

During the 5-year follow-up, a total of 487 T2D patients (4.6 percent) developed major renal events (defined as development of new macroalbuminuria, doubling of creatinine, end-stage renal disease or renal death). On multivariable Cox analysis, the risk increased with increasing BMI. The hazard ratios (HRs) for major renal event were 0.91 (95 percent CI, 0.72–1.15) in overweight patients, 1.03 (0.77–1.37) in those with grade 1 obesity, 1.42 (0.98–2.07) in those with grade 2 and 2.16 (1.34–3.48) in those with grade 3 (p=0.006).

The elevated major renal event risk observed with greater BMI was observed across subgroups by randomized interventions (intensive vs standard glucose control and perindopril-indapamide vs placebo). Every additional unit of BMI over 25 kg/m2 was associated with a 4-percent increase in the risk of major renal events.

Similar results were observed for the secondary endpoints of the development of new microalbuminuria and the individual components of the composite of major renal adverse events.

The present data encourage comprehensive and motivated weight loss programmes for improving the prevention of the development and progression of kidney complications in patients with both T2D and obesity, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
Treatment with oral thrombopoietin receptor agonist eltrombopag leads to similar platelet counts in patients with chronic immune thrombocytopaenia (cITP) and persistent (per)ITP, according to the results of phase III (EXTEND) and IV studies presented at the 23rd Congress of the European Hematology Association (EHA 2018) held in Stockholm, Sweden.
4 days ago
Socioeconomic status, along with other social determinants, appears to influence the long-term outcomes in Asian acute heart failure patients, according to a recent Japan study.
Pearl Toh, 6 days ago
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
Jairia Dela Cruz, 4 days ago
A treatment regimen combining daratumumab plus bortezomib, melphalan and prednisone markedly extends progression-free survival in patients with multiple myeloma, inducing deep responses and demonstrating acceptable tolerability regardless of baseline renal function, according to the results of the phase III ALCYONE study.